Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
D2B3 Logo
D2B3 Growth Score
60
CB Rank
92917
Heat Score
62
D2B3is a pre-clinical biotechnology startup dedicated to creating innovative drug delivery technologies for the brain.
PrivatePre-Seed New Haven, Connecticut, United States1-10 d2b3.bio
Biotechnology
Overview

D2B3
Total Funding
obfuscation
Growth Score
60
Heat Score
62

Total Funding
obfuscation
obfuscation
Pre-Seed raised
obfuscation
Growth Score60
-6 pts
in past quarter
Heat Score 62
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About D2B3

CB Rank
92917
D2B3is a pre-clinical biotechnology startup dedicated to creating innovative drug delivery technologies for the brain.
PrivatePre-Seed New Haven, Connecticut, United States1-10 d2b3.bio
Biotechnology

Funding Rounds

Pre-Seed
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Anne Eichmann, Kevin Boye, Manuel Mohr
About the Company
D2B3 is a pre-clinical biotechnology startup dedicated to creating innovative drug delivery technologies for the brain and central nervous system.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

Proprietary Blood-Brain Barrier Opening Technology
A technology that transiently and specifically opens the blood-brain barrier to enable therapeutic targeting of central nervous system diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Pre Seed Round - D2B3 Logo
Pre Seed Round - D2B3
1
obfuscation
Mission BioCapitalPre-Seed
obfuscation
Pre Seed Round - D2B3 Logo
Pre Seed Round - D2B3
1
obfuscation
Mission BioCapitalPre-Seed
obfuscation
Pre Seed Round - D2B3 Logo
Pre Seed Round - D2B3
1
obfuscation
Mission BioCapitalPre-Seed
obfuscation
Pre Seed Round - D2B3 Logo
Pre Seed Round - D2B3
1
obfuscation
Mission BioCapitalPre-Seed
obfuscation
Pre Seed Round - D2B3 Logo
Pre Seed Round - D2B3
1
obfuscation
Mission BioCapitalPre-Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Pre Seed Round - D2B3 Logo
Pre Seed Round - D2B3
1
obfuscation
Mission BioCapitalPre-Seed
obfuscation
Pre Seed Round - D2B3 Logo
Pre Seed Round - D2B3
1
obfuscation
Mission BioCapitalPre-Seed
obfuscation
Pre Seed Round - D2B3 Logo
Pre Seed Round - D2B3
1
obfuscation
Mission BioCapitalPre-Seed
obfuscation
Pre Seed Round - D2B3 Logo
Pre Seed Round - D2B3
1
obfuscation
Mission BioCapitalPre-Seed
obfuscation
Pre Seed Round - D2B3 Logo
Pre Seed Round - D2B3
1
obfuscation
Mission BioCapitalPre-Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

283

IT Spend

$22.5KThis year, D2B3 is projected to spend $22.5K on IT, according to Aberdeen.

Active Website Tech Count

2D2B3 is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is D2B3's headquarters? D2B3 is located in New Haven, Connecticut, United States.Who invested in D2B3? D2B3 is funded by Mission BioCapital.When was the last funding round for D2B3? D2B3 closed its last funding round on
obfuscation
from a Pre-Seed round.Who are D2B3's competitors? Alternatives and possible competitors to D2B3 may include InSightec, CarThera, and  ABL Bio.How much funding has D2B3 raised to date? D2B3 has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|